Mary M. Barna, PharmD
Advertisement
Articles by Mary M. Barna, PharmD
Alzheimer's disease represents a mounting public health problem and clinicians need a strong understanding of both the disease and its various treatment modalities.
When discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.
Advertisement
Latest Updated Articles
- Managing Opioid- Induced Constipation
Published: September 15th 2009 | Updated:
- Alzheimer's Disease: Slowing Down the Course
Published: March 1st 2009 | Updated:
- Overactive Bladder Disease: Overcoming the Urge to Go
Published: January 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants National Priority Vouchers to Enlicitide Decanoate, Sacituzumab Tirumotecan
2
Toothpaste Tablets Are Gaining Popularity—Here’s Where Pharmacists Fit In
3
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
4
Twists, Turns, and Tapers: Navigating the Benzodiazepine Ride
5